EXPERIMENTAL AND MOLECULAR MEDICINE-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2155086, encodeId=bf482155086bb, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：正在投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=724a2115896, createdName=1581f9a412m, createdTime=Tue Aug 29 08:33:36 CST 2023, time=2023-08-29, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2131164, encodeId=78cc213116439, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：非常慢，慢，慢，2个多月状态一直是投稿状态，没有任何改变。editor还么有来及去关注稿件是否适合他们杂志。建议时间急的，千万不要投。写信杂志社也不会回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99ec2258493, createdName=1217be29m97(暂无昵称), createdTime=Tue May 09 15:49:03 CST 2023, time=2023-05-09, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2139423, encodeId=819f213942367, content=23.03.30投稿 23.04.02形式审查通过 23.05.01邀请2个审稿人 23.05.02-03审稿人均同意审稿 23.05.16审稿人1意见返回 23.05.24审稿人2意见返回后面不知道还要多久……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3115564205, createdName=ms1000001765034927, createdTime=Sat May 27 21:27:05 CST 2023, time=2023-05-27, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2140613, encodeId=1152214061377, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：审稿极其慢，编辑部每次回复意见都是敷衍，不明白编辑部都在干啥 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8da12982265, createdName=seudoctorxie, createdTime=Sat Jun 03 11:35:01 CST 2023, time=2023-06-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2146224, encodeId=f46f21462246f, content=水刊。。。不建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210205/05b5037b86db4c98a206f2987b4d2b0a/90631ca66a734b018e412f1891933dce.jpg, createdBy=6a6f1855273, createdName=小甜甜66, createdTime=Tue Jul 04 07:37:19 CST 2023, time=2023-07-04, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2118088, encodeId=2339211808828, content=Research Square上能看到审稿进度。我1月31日投稿，2月17日分配编辑，3月2日邀请审稿人，邀请了两个，3月6日显示已经收到两个审稿意见。希望有个好结果🙏🏻🙏🏻🙏🏻🙏🏻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc388334751, createdName=ms1000000326683554, createdTime=Tue Mar 07 10:55:10 CST 2023, time=2023-03-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2133435, encodeId=80832133435b4, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：审稿速度超级慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99ec2258493, createdName=1217be29m97(暂无昵称), createdTime=Sat May 13 14:45:50 CST 2023, time=2023-05-13, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2124397, encodeId=55c4212439edc, content=二审要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/19/9fed0a27d14f8b827343de9cb3cd3267.jpg, createdBy=40602297737, createdName=伪面君子, createdTime=Sat Apr 08 02:42:05 CST 2023, time=2023-04-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2125067, encodeId=acde212506e1a, content=审稿速度:3.0 偏重的研究方向：基础研究并结合临床转化为特点 经验分享：这个杂志极其的慢，投稿后状态就是under review。杂志首页说的first decision日期为25天，指的是25天由编辑决定是否送外审。之后的外审还有1-2个月时间。除了韩国自己人的审稿速度快，，其他国家基本都是很慢的周期！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8da12982265, createdName=seudoctorxie, createdTime=Tue Apr 11 12:39:31 CST 2023, time=2023-04-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2127485, encodeId=b634212e485c8, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：审稿速度非常慢，投稿一个多月，editor都还没有处理，email杂志社也不回。对审稿速度有要求的，建议不要投该杂志。杂志社与主编处理稿件非常慢，无论是初次投稿，还是返修！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99ec2258493, createdName=1217be29m97(暂无昵称), createdTime=Fri Apr 21 14:57:54 CST 2023, time=2023-04-21, status=1, ipAttribution=重庆)]

2023-08-29 1581f9a412m 来自贵州省

审稿速度:2.0 | 投稿命中率:25.0
经验分享：正在投稿

50 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2155086, encodeId=bf482155086bb, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：正在投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=724a2115896, createdName=1581f9a412m, createdTime=Tue Aug 29 08:33:36 CST 2023, time=2023-08-29, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2131164, encodeId=78cc213116439, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：非常慢，慢，慢，2个多月状态一直是投稿状态，没有任何改变。editor还么有来及去关注稿件是否适合他们杂志。建议时间急的，千万不要投。写信杂志社也不会回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99ec2258493, createdName=1217be29m97(暂无昵称), createdTime=Tue May 09 15:49:03 CST 2023, time=2023-05-09, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2139423, encodeId=819f213942367, content=23.03.30投稿 23.04.02形式审查通过 23.05.01邀请2个审稿人 23.05.02-03审稿人均同意审稿 23.05.16审稿人1意见返回 23.05.24审稿人2意见返回后面不知道还要多久……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3115564205, createdName=ms1000001765034927, createdTime=Sat May 27 21:27:05 CST 2023, time=2023-05-27, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2140613, encodeId=1152214061377, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：审稿极其慢，编辑部每次回复意见都是敷衍，不明白编辑部都在干啥 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8da12982265, createdName=seudoctorxie, createdTime=Sat Jun 03 11:35:01 CST 2023, time=2023-06-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2146224, encodeId=f46f21462246f, content=水刊。。。不建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210205/05b5037b86db4c98a206f2987b4d2b0a/90631ca66a734b018e412f1891933dce.jpg, createdBy=6a6f1855273, createdName=小甜甜66, createdTime=Tue Jul 04 07:37:19 CST 2023, time=2023-07-04, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2118088, encodeId=2339211808828, content=Research Square上能看到审稿进度。我1月31日投稿，2月17日分配编辑，3月2日邀请审稿人，邀请了两个，3月6日显示已经收到两个审稿意见。希望有个好结果🙏🏻🙏🏻🙏🏻🙏🏻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc388334751, createdName=ms1000000326683554, createdTime=Tue Mar 07 10:55:10 CST 2023, time=2023-03-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2133435, encodeId=80832133435b4, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：审稿速度超级慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99ec2258493, createdName=1217be29m97(暂无昵称), createdTime=Sat May 13 14:45:50 CST 2023, time=2023-05-13, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2124397, encodeId=55c4212439edc, content=二审要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/19/9fed0a27d14f8b827343de9cb3cd3267.jpg, createdBy=40602297737, createdName=伪面君子, createdTime=Sat Apr 08 02:42:05 CST 2023, time=2023-04-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2125067, encodeId=acde212506e1a, content=审稿速度:3.0 偏重的研究方向：基础研究并结合临床转化为特点 经验分享：这个杂志极其的慢，投稿后状态就是under review。杂志首页说的first decision日期为25天，指的是25天由编辑决定是否送外审。之后的外审还有1-2个月时间。除了韩国自己人的审稿速度快，，其他国家基本都是很慢的周期！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8da12982265, createdName=seudoctorxie, createdTime=Tue Apr 11 12:39:31 CST 2023, time=2023-04-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2127485, encodeId=b634212e485c8, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：审稿速度非常慢，投稿一个多月，editor都还没有处理，email杂志社也不回。对审稿速度有要求的，建议不要投该杂志。杂志社与主编处理稿件非常慢，无论是初次投稿，还是返修！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99ec2258493, createdName=1217be29m97(暂无昵称), createdTime=Fri Apr 21 14:57:54 CST 2023, time=2023-04-21, status=1, ipAttribution=重庆)]

2023-05-09 1217be29m97(暂无昵称) 来自重庆

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤
经验分享：非常慢，慢，慢，2个多月状态一直是投稿状态，没有任何改变。editor还么有来及去关注稿件是否适合他们杂志。建议时间急的，千万不要投。写信杂志社也不会回复。

46 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2155086, encodeId=bf482155086bb, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：正在投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=724a2115896, createdName=1581f9a412m, createdTime=Tue Aug 29 08:33:36 CST 2023, time=2023-08-29, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2131164, encodeId=78cc213116439, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：非常慢，慢，慢，2个多月状态一直是投稿状态，没有任何改变。editor还么有来及去关注稿件是否适合他们杂志。建议时间急的，千万不要投。写信杂志社也不会回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99ec2258493, createdName=1217be29m97(暂无昵称), createdTime=Tue May 09 15:49:03 CST 2023, time=2023-05-09, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2139423, encodeId=819f213942367, content=23.03.30投稿 23.04.02形式审查通过 23.05.01邀请2个审稿人 23.05.02-03审稿人均同意审稿 23.05.16审稿人1意见返回 23.05.24审稿人2意见返回后面不知道还要多久……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3115564205, createdName=ms1000001765034927, createdTime=Sat May 27 21:27:05 CST 2023, time=2023-05-27, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2140613, encodeId=1152214061377, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：审稿极其慢，编辑部每次回复意见都是敷衍，不明白编辑部都在干啥 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8da12982265, createdName=seudoctorxie, createdTime=Sat Jun 03 11:35:01 CST 2023, time=2023-06-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2146224, encodeId=f46f21462246f, content=水刊。。。不建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210205/05b5037b86db4c98a206f2987b4d2b0a/90631ca66a734b018e412f1891933dce.jpg, createdBy=6a6f1855273, createdName=小甜甜66, createdTime=Tue Jul 04 07:37:19 CST 2023, time=2023-07-04, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2118088, encodeId=2339211808828, content=Research Square上能看到审稿进度。我1月31日投稿，2月17日分配编辑，3月2日邀请审稿人，邀请了两个，3月6日显示已经收到两个审稿意见。希望有个好结果🙏🏻🙏🏻🙏🏻🙏🏻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc388334751, createdName=ms1000000326683554, createdTime=Tue Mar 07 10:55:10 CST 2023, time=2023-03-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2133435, encodeId=80832133435b4, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：审稿速度超级慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99ec2258493, createdName=1217be29m97(暂无昵称), createdTime=Sat May 13 14:45:50 CST 2023, time=2023-05-13, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2124397, encodeId=55c4212439edc, content=二审要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/19/9fed0a27d14f8b827343de9cb3cd3267.jpg, createdBy=40602297737, createdName=伪面君子, createdTime=Sat Apr 08 02:42:05 CST 2023, time=2023-04-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2125067, encodeId=acde212506e1a, content=审稿速度:3.0 偏重的研究方向：基础研究并结合临床转化为特点 经验分享：这个杂志极其的慢，投稿后状态就是under review。杂志首页说的first decision日期为25天，指的是25天由编辑决定是否送外审。之后的外审还有1-2个月时间。除了韩国自己人的审稿速度快，，其他国家基本都是很慢的周期！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8da12982265, createdName=seudoctorxie, createdTime=Tue Apr 11 12:39:31 CST 2023, time=2023-04-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2127485, encodeId=b634212e485c8, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：审稿速度非常慢，投稿一个多月，editor都还没有处理，email杂志社也不回。对审稿速度有要求的，建议不要投该杂志。杂志社与主编处理稿件非常慢，无论是初次投稿，还是返修！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99ec2258493, createdName=1217be29m97(暂无昵称), createdTime=Fri Apr 21 14:57:54 CST 2023, time=2023-04-21, status=1, ipAttribution=重庆)]

2023-05-27 ms1000001765034927 来自陕西省

23.03.30投稿 23.04.02形式审查通过 23.05.01邀请2个审稿人 23.05.02-03审稿人均同意审稿 23.05.16审稿人1意见返回 23.05.24审稿人2意见返回后面不知道还要多久……

52 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2155086, encodeId=bf482155086bb, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：正在投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=724a2115896, createdName=1581f9a412m, createdTime=Tue Aug 29 08:33:36 CST 2023, time=2023-08-29, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2131164, encodeId=78cc213116439, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：非常慢，慢，慢，2个多月状态一直是投稿状态，没有任何改变。editor还么有来及去关注稿件是否适合他们杂志。建议时间急的，千万不要投。写信杂志社也不会回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99ec2258493, createdName=1217be29m97(暂无昵称), createdTime=Tue May 09 15:49:03 CST 2023, time=2023-05-09, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2139423, encodeId=819f213942367, content=23.03.30投稿 23.04.02形式审查通过 23.05.01邀请2个审稿人 23.05.02-03审稿人均同意审稿 23.05.16审稿人1意见返回 23.05.24审稿人2意见返回后面不知道还要多久……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3115564205, createdName=ms1000001765034927, createdTime=Sat May 27 21:27:05 CST 2023, time=2023-05-27, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2140613, encodeId=1152214061377, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：审稿极其慢，编辑部每次回复意见都是敷衍，不明白编辑部都在干啥 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8da12982265, createdName=seudoctorxie, createdTime=Sat Jun 03 11:35:01 CST 2023, time=2023-06-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2146224, encodeId=f46f21462246f, content=水刊。。。不建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210205/05b5037b86db4c98a206f2987b4d2b0a/90631ca66a734b018e412f1891933dce.jpg, createdBy=6a6f1855273, createdName=小甜甜66, createdTime=Tue Jul 04 07:37:19 CST 2023, time=2023-07-04, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2118088, encodeId=2339211808828, content=Research Square上能看到审稿进度。我1月31日投稿，2月17日分配编辑，3月2日邀请审稿人，邀请了两个，3月6日显示已经收到两个审稿意见。希望有个好结果🙏🏻🙏🏻🙏🏻🙏🏻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc388334751, createdName=ms1000000326683554, createdTime=Tue Mar 07 10:55:10 CST 2023, time=2023-03-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2133435, encodeId=80832133435b4, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：审稿速度超级慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99ec2258493, createdName=1217be29m97(暂无昵称), createdTime=Sat May 13 14:45:50 CST 2023, time=2023-05-13, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2124397, encodeId=55c4212439edc, content=二审要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/19/9fed0a27d14f8b827343de9cb3cd3267.jpg, createdBy=40602297737, createdName=伪面君子, createdTime=Sat Apr 08 02:42:05 CST 2023, time=2023-04-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2125067, encodeId=acde212506e1a, content=审稿速度:3.0 偏重的研究方向：基础研究并结合临床转化为特点 经验分享：这个杂志极其的慢，投稿后状态就是under review。杂志首页说的first decision日期为25天，指的是25天由编辑决定是否送外审。之后的外审还有1-2个月时间。除了韩国自己人的审稿速度快，，其他国家基本都是很慢的周期！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8da12982265, createdName=seudoctorxie, createdTime=Tue Apr 11 12:39:31 CST 2023, time=2023-04-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2127485, encodeId=b634212e485c8, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：审稿速度非常慢，投稿一个多月，editor都还没有处理，email杂志社也不回。对审稿速度有要求的，建议不要投该杂志。杂志社与主编处理稿件非常慢，无论是初次投稿，还是返修！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99ec2258493, createdName=1217be29m97(暂无昵称), createdTime=Fri Apr 21 14:57:54 CST 2023, time=2023-04-21, status=1, ipAttribution=重庆)]

2023-06-03 seudoctorxie 来自江苏省

审稿速度:6.0 | 投稿命中率:25.0
经验分享：审稿极其慢，编辑部每次回复意见都是敷衍，不明白编辑部都在干啥

0 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2155086, encodeId=bf482155086bb, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：正在投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=724a2115896, createdName=1581f9a412m, createdTime=Tue Aug 29 08:33:36 CST 2023, time=2023-08-29, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2131164, encodeId=78cc213116439, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：非常慢，慢，慢，2个多月状态一直是投稿状态，没有任何改变。editor还么有来及去关注稿件是否适合他们杂志。建议时间急的，千万不要投。写信杂志社也不会回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99ec2258493, createdName=1217be29m97(暂无昵称), createdTime=Tue May 09 15:49:03 CST 2023, time=2023-05-09, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2139423, encodeId=819f213942367, content=23.03.30投稿 23.04.02形式审查通过 23.05.01邀请2个审稿人 23.05.02-03审稿人均同意审稿 23.05.16审稿人1意见返回 23.05.24审稿人2意见返回后面不知道还要多久……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3115564205, createdName=ms1000001765034927, createdTime=Sat May 27 21:27:05 CST 2023, time=2023-05-27, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2140613, encodeId=1152214061377, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：审稿极其慢，编辑部每次回复意见都是敷衍，不明白编辑部都在干啥 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8da12982265, createdName=seudoctorxie, createdTime=Sat Jun 03 11:35:01 CST 2023, time=2023-06-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2146224, encodeId=f46f21462246f, content=水刊。。。不建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210205/05b5037b86db4c98a206f2987b4d2b0a/90631ca66a734b018e412f1891933dce.jpg, createdBy=6a6f1855273, createdName=小甜甜66, createdTime=Tue Jul 04 07:37:19 CST 2023, time=2023-07-04, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2118088, encodeId=2339211808828, content=Research Square上能看到审稿进度。我1月31日投稿，2月17日分配编辑，3月2日邀请审稿人，邀请了两个，3月6日显示已经收到两个审稿意见。希望有个好结果🙏🏻🙏🏻🙏🏻🙏🏻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc388334751, createdName=ms1000000326683554, createdTime=Tue Mar 07 10:55:10 CST 2023, time=2023-03-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2133435, encodeId=80832133435b4, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：审稿速度超级慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99ec2258493, createdName=1217be29m97(暂无昵称), createdTime=Sat May 13 14:45:50 CST 2023, time=2023-05-13, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2124397, encodeId=55c4212439edc, content=二审要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/19/9fed0a27d14f8b827343de9cb3cd3267.jpg, createdBy=40602297737, createdName=伪面君子, createdTime=Sat Apr 08 02:42:05 CST 2023, time=2023-04-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2125067, encodeId=acde212506e1a, content=审稿速度:3.0 偏重的研究方向：基础研究并结合临床转化为特点 经验分享：这个杂志极其的慢，投稿后状态就是under review。杂志首页说的first decision日期为25天，指的是25天由编辑决定是否送外审。之后的外审还有1-2个月时间。除了韩国自己人的审稿速度快，，其他国家基本都是很慢的周期！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8da12982265, createdName=seudoctorxie, createdTime=Tue Apr 11 12:39:31 CST 2023, time=2023-04-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2127485, encodeId=b634212e485c8, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：审稿速度非常慢，投稿一个多月，editor都还没有处理，email杂志社也不回。对审稿速度有要求的，建议不要投该杂志。杂志社与主编处理稿件非常慢，无论是初次投稿，还是返修！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99ec2258493, createdName=1217be29m97(暂无昵称), createdTime=Fri Apr 21 14:57:54 CST 2023, time=2023-04-21, status=1, ipAttribution=重庆)]

2023-07-04 小甜甜66 来自湖北省

水刊。。。不建议

38 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2155086, encodeId=bf482155086bb, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：正在投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=724a2115896, createdName=1581f9a412m, createdTime=Tue Aug 29 08:33:36 CST 2023, time=2023-08-29, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2131164, encodeId=78cc213116439, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：非常慢，慢，慢，2个多月状态一直是投稿状态，没有任何改变。editor还么有来及去关注稿件是否适合他们杂志。建议时间急的，千万不要投。写信杂志社也不会回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99ec2258493, createdName=1217be29m97(暂无昵称), createdTime=Tue May 09 15:49:03 CST 2023, time=2023-05-09, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2139423, encodeId=819f213942367, content=23.03.30投稿 23.04.02形式审查通过 23.05.01邀请2个审稿人 23.05.02-03审稿人均同意审稿 23.05.16审稿人1意见返回 23.05.24审稿人2意见返回后面不知道还要多久……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3115564205, createdName=ms1000001765034927, createdTime=Sat May 27 21:27:05 CST 2023, time=2023-05-27, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2140613, encodeId=1152214061377, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：审稿极其慢，编辑部每次回复意见都是敷衍，不明白编辑部都在干啥 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8da12982265, createdName=seudoctorxie, createdTime=Sat Jun 03 11:35:01 CST 2023, time=2023-06-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2146224, encodeId=f46f21462246f, content=水刊。。。不建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210205/05b5037b86db4c98a206f2987b4d2b0a/90631ca66a734b018e412f1891933dce.jpg, createdBy=6a6f1855273, createdName=小甜甜66, createdTime=Tue Jul 04 07:37:19 CST 2023, time=2023-07-04, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2118088, encodeId=2339211808828, content=Research Square上能看到审稿进度。我1月31日投稿，2月17日分配编辑，3月2日邀请审稿人，邀请了两个，3月6日显示已经收到两个审稿意见。希望有个好结果🙏🏻🙏🏻🙏🏻🙏🏻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc388334751, createdName=ms1000000326683554, createdTime=Tue Mar 07 10:55:10 CST 2023, time=2023-03-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2133435, encodeId=80832133435b4, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：审稿速度超级慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99ec2258493, createdName=1217be29m97(暂无昵称), createdTime=Sat May 13 14:45:50 CST 2023, time=2023-05-13, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2124397, encodeId=55c4212439edc, content=二审要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/19/9fed0a27d14f8b827343de9cb3cd3267.jpg, createdBy=40602297737, createdName=伪面君子, createdTime=Sat Apr 08 02:42:05 CST 2023, time=2023-04-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2125067, encodeId=acde212506e1a, content=审稿速度:3.0 偏重的研究方向：基础研究并结合临床转化为特点 经验分享：这个杂志极其的慢，投稿后状态就是under review。杂志首页说的first decision日期为25天，指的是25天由编辑决定是否送外审。之后的外审还有1-2个月时间。除了韩国自己人的审稿速度快，，其他国家基本都是很慢的周期！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8da12982265, createdName=seudoctorxie, createdTime=Tue Apr 11 12:39:31 CST 2023, time=2023-04-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2127485, encodeId=b634212e485c8, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：审稿速度非常慢，投稿一个多月，editor都还没有处理，email杂志社也不回。对审稿速度有要求的，建议不要投该杂志。杂志社与主编处理稿件非常慢，无论是初次投稿，还是返修！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99ec2258493, createdName=1217be29m97(暂无昵称), createdTime=Fri Apr 21 14:57:54 CST 2023, time=2023-04-21, status=1, ipAttribution=重庆)]

2023-03-07 ms1000000326683554 来自江苏省

Research Square上能看到审稿进度。我1月31日投稿，2月17日分配编辑，3月2日邀请审稿人，邀请了两个，3月6日显示已经收到两个审稿意见。希望有个好结果🙏🏻🙏🏻🙏🏻🙏🏻

0 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2155086, encodeId=bf482155086bb, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：正在投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=724a2115896, createdName=1581f9a412m, createdTime=Tue Aug 29 08:33:36 CST 2023, time=2023-08-29, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2131164, encodeId=78cc213116439, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：非常慢，慢，慢，2个多月状态一直是投稿状态，没有任何改变。editor还么有来及去关注稿件是否适合他们杂志。建议时间急的，千万不要投。写信杂志社也不会回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99ec2258493, createdName=1217be29m97(暂无昵称), createdTime=Tue May 09 15:49:03 CST 2023, time=2023-05-09, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2139423, encodeId=819f213942367, content=23.03.30投稿 23.04.02形式审查通过 23.05.01邀请2个审稿人 23.05.02-03审稿人均同意审稿 23.05.16审稿人1意见返回 23.05.24审稿人2意见返回后面不知道还要多久……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3115564205, createdName=ms1000001765034927, createdTime=Sat May 27 21:27:05 CST 2023, time=2023-05-27, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2140613, encodeId=1152214061377, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：审稿极其慢，编辑部每次回复意见都是敷衍，不明白编辑部都在干啥 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8da12982265, createdName=seudoctorxie, createdTime=Sat Jun 03 11:35:01 CST 2023, time=2023-06-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2146224, encodeId=f46f21462246f, content=水刊。。。不建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210205/05b5037b86db4c98a206f2987b4d2b0a/90631ca66a734b018e412f1891933dce.jpg, createdBy=6a6f1855273, createdName=小甜甜66, createdTime=Tue Jul 04 07:37:19 CST 2023, time=2023-07-04, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2118088, encodeId=2339211808828, content=Research Square上能看到审稿进度。我1月31日投稿，2月17日分配编辑，3月2日邀请审稿人，邀请了两个，3月6日显示已经收到两个审稿意见。希望有个好结果🙏🏻🙏🏻🙏🏻🙏🏻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc388334751, createdName=ms1000000326683554, createdTime=Tue Mar 07 10:55:10 CST 2023, time=2023-03-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2133435, encodeId=80832133435b4, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：审稿速度超级慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99ec2258493, createdName=1217be29m97(暂无昵称), createdTime=Sat May 13 14:45:50 CST 2023, time=2023-05-13, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2124397, encodeId=55c4212439edc, content=二审要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/19/9fed0a27d14f8b827343de9cb3cd3267.jpg, createdBy=40602297737, createdName=伪面君子, createdTime=Sat Apr 08 02:42:05 CST 2023, time=2023-04-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2125067, encodeId=acde212506e1a, content=审稿速度:3.0 偏重的研究方向：基础研究并结合临床转化为特点 经验分享：这个杂志极其的慢，投稿后状态就是under review。杂志首页说的first decision日期为25天，指的是25天由编辑决定是否送外审。之后的外审还有1-2个月时间。除了韩国自己人的审稿速度快，，其他国家基本都是很慢的周期！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8da12982265, createdName=seudoctorxie, createdTime=Tue Apr 11 12:39:31 CST 2023, time=2023-04-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2127485, encodeId=b634212e485c8, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：审稿速度非常慢，投稿一个多月，editor都还没有处理，email杂志社也不回。对审稿速度有要求的，建议不要投该杂志。杂志社与主编处理稿件非常慢，无论是初次投稿，还是返修！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99ec2258493, createdName=1217be29m97(暂无昵称), createdTime=Fri Apr 21 14:57:54 CST 2023, time=2023-04-21, status=1, ipAttribution=重庆)]

2023-05-13 1217be29m97(暂无昵称) 来自重庆

审稿速度:12.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤
经验分享：审稿速度超级慢

27 0

[GetPortalCommentsPageByObjectIdResponse(id=2155086, encodeId=bf482155086bb, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：正在投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=724a2115896, createdName=1581f9a412m, createdTime=Tue Aug 29 08:33:36 CST 2023, time=2023-08-29, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2131164, encodeId=78cc213116439, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：非常慢，慢，慢，2个多月状态一直是投稿状态，没有任何改变。editor还么有来及去关注稿件是否适合他们杂志。建议时间急的，千万不要投。写信杂志社也不会回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99ec2258493, createdName=1217be29m97(暂无昵称), createdTime=Tue May 09 15:49:03 CST 2023, time=2023-05-09, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2139423, encodeId=819f213942367, content=23.03.30投稿 23.04.02形式审查通过 23.05.01邀请2个审稿人 23.05.02-03审稿人均同意审稿 23.05.16审稿人1意见返回 23.05.24审稿人2意见返回后面不知道还要多久……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3115564205, createdName=ms1000001765034927, createdTime=Sat May 27 21:27:05 CST 2023, time=2023-05-27, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2140613, encodeId=1152214061377, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：审稿极其慢，编辑部每次回复意见都是敷衍，不明白编辑部都在干啥 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8da12982265, createdName=seudoctorxie, createdTime=Sat Jun 03 11:35:01 CST 2023, time=2023-06-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2146224, encodeId=f46f21462246f, content=水刊。。。不建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210205/05b5037b86db4c98a206f2987b4d2b0a/90631ca66a734b018e412f1891933dce.jpg, createdBy=6a6f1855273, createdName=小甜甜66, createdTime=Tue Jul 04 07:37:19 CST 2023, time=2023-07-04, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2118088, encodeId=2339211808828, content=Research Square上能看到审稿进度。我1月31日投稿，2月17日分配编辑，3月2日邀请审稿人，邀请了两个，3月6日显示已经收到两个审稿意见。希望有个好结果🙏🏻🙏🏻🙏🏻🙏🏻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc388334751, createdName=ms1000000326683554, createdTime=Tue Mar 07 10:55:10 CST 2023, time=2023-03-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2133435, encodeId=80832133435b4, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：审稿速度超级慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99ec2258493, createdName=1217be29m97(暂无昵称), createdTime=Sat May 13 14:45:50 CST 2023, time=2023-05-13, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2124397, encodeId=55c4212439edc, content=二审要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/19/9fed0a27d14f8b827343de9cb3cd3267.jpg, createdBy=40602297737, createdName=伪面君子, createdTime=Sat Apr 08 02:42:05 CST 2023, time=2023-04-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2125067, encodeId=acde212506e1a, content=审稿速度:3.0 偏重的研究方向：基础研究并结合临床转化为特点 经验分享：这个杂志极其的慢，投稿后状态就是under review。杂志首页说的first decision日期为25天，指的是25天由编辑决定是否送外审。之后的外审还有1-2个月时间。除了韩国自己人的审稿速度快，，其他国家基本都是很慢的周期！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8da12982265, createdName=seudoctorxie, createdTime=Tue Apr 11 12:39:31 CST 2023, time=2023-04-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2127485, encodeId=b634212e485c8, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：审稿速度非常慢，投稿一个多月，editor都还没有处理，email杂志社也不回。对审稿速度有要求的，建议不要投该杂志。杂志社与主编处理稿件非常慢，无论是初次投稿，还是返修！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99ec2258493, createdName=1217be29m97(暂无昵称), createdTime=Fri Apr 21 14:57:54 CST 2023, time=2023-04-21, status=1, ipAttribution=重庆)]

2023-04-08 伪面君子来自湖北省

二审要多久

34 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2155086, encodeId=bf482155086bb, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：正在投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=724a2115896, createdName=1581f9a412m, createdTime=Tue Aug 29 08:33:36 CST 2023, time=2023-08-29, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2131164, encodeId=78cc213116439, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：非常慢，慢，慢，2个多月状态一直是投稿状态，没有任何改变。editor还么有来及去关注稿件是否适合他们杂志。建议时间急的，千万不要投。写信杂志社也不会回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99ec2258493, createdName=1217be29m97(暂无昵称), createdTime=Tue May 09 15:49:03 CST 2023, time=2023-05-09, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2139423, encodeId=819f213942367, content=23.03.30投稿 23.04.02形式审查通过 23.05.01邀请2个审稿人 23.05.02-03审稿人均同意审稿 23.05.16审稿人1意见返回 23.05.24审稿人2意见返回后面不知道还要多久……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3115564205, createdName=ms1000001765034927, createdTime=Sat May 27 21:27:05 CST 2023, time=2023-05-27, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2140613, encodeId=1152214061377, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：审稿极其慢，编辑部每次回复意见都是敷衍，不明白编辑部都在干啥 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8da12982265, createdName=seudoctorxie, createdTime=Sat Jun 03 11:35:01 CST 2023, time=2023-06-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2146224, encodeId=f46f21462246f, content=水刊。。。不建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210205/05b5037b86db4c98a206f2987b4d2b0a/90631ca66a734b018e412f1891933dce.jpg, createdBy=6a6f1855273, createdName=小甜甜66, createdTime=Tue Jul 04 07:37:19 CST 2023, time=2023-07-04, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2118088, encodeId=2339211808828, content=Research Square上能看到审稿进度。我1月31日投稿，2月17日分配编辑，3月2日邀请审稿人，邀请了两个，3月6日显示已经收到两个审稿意见。希望有个好结果🙏🏻🙏🏻🙏🏻🙏🏻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc388334751, createdName=ms1000000326683554, createdTime=Tue Mar 07 10:55:10 CST 2023, time=2023-03-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2133435, encodeId=80832133435b4, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：审稿速度超级慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99ec2258493, createdName=1217be29m97(暂无昵称), createdTime=Sat May 13 14:45:50 CST 2023, time=2023-05-13, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2124397, encodeId=55c4212439edc, content=二审要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/19/9fed0a27d14f8b827343de9cb3cd3267.jpg, createdBy=40602297737, createdName=伪面君子, createdTime=Sat Apr 08 02:42:05 CST 2023, time=2023-04-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2125067, encodeId=acde212506e1a, content=审稿速度:3.0 偏重的研究方向：基础研究并结合临床转化为特点 经验分享：这个杂志极其的慢，投稿后状态就是under review。杂志首页说的first decision日期为25天，指的是25天由编辑决定是否送外审。之后的外审还有1-2个月时间。除了韩国自己人的审稿速度快，，其他国家基本都是很慢的周期！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8da12982265, createdName=seudoctorxie, createdTime=Tue Apr 11 12:39:31 CST 2023, time=2023-04-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2127485, encodeId=b634212e485c8, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：审稿速度非常慢，投稿一个多月，editor都还没有处理，email杂志社也不回。对审稿速度有要求的，建议不要投该杂志。杂志社与主编处理稿件非常慢，无论是初次投稿，还是返修！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99ec2258493, createdName=1217be29m97(暂无昵称), createdTime=Fri Apr 21 14:57:54 CST 2023, time=2023-04-21, status=1, ipAttribution=重庆)]

2023-04-11 seudoctorxie 来自江苏省

审稿速度:3.0
偏重的研究方向：基础研究并结合临床转化为特点
经验分享：这个杂志极其的慢，投稿后状态就是under review。杂志首页说的first decision日期为25天，指的是25天由编辑决定是否送外审。之后的外审还有1-2个月时间。除了韩国自己人的审稿速度快，，其他国家基本都是很慢的周期！

43 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2155086, encodeId=bf482155086bb, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：正在投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=724a2115896, createdName=1581f9a412m, createdTime=Tue Aug 29 08:33:36 CST 2023, time=2023-08-29, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2131164, encodeId=78cc213116439, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：非常慢，慢，慢，2个多月状态一直是投稿状态，没有任何改变。editor还么有来及去关注稿件是否适合他们杂志。建议时间急的，千万不要投。写信杂志社也不会回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99ec2258493, createdName=1217be29m97(暂无昵称), createdTime=Tue May 09 15:49:03 CST 2023, time=2023-05-09, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2139423, encodeId=819f213942367, content=23.03.30投稿 23.04.02形式审查通过 23.05.01邀请2个审稿人 23.05.02-03审稿人均同意审稿 23.05.16审稿人1意见返回 23.05.24审稿人2意见返回后面不知道还要多久……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3115564205, createdName=ms1000001765034927, createdTime=Sat May 27 21:27:05 CST 2023, time=2023-05-27, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2140613, encodeId=1152214061377, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：审稿极其慢，编辑部每次回复意见都是敷衍，不明白编辑部都在干啥 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8da12982265, createdName=seudoctorxie, createdTime=Sat Jun 03 11:35:01 CST 2023, time=2023-06-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2146224, encodeId=f46f21462246f, content=水刊。。。不建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210205/05b5037b86db4c98a206f2987b4d2b0a/90631ca66a734b018e412f1891933dce.jpg, createdBy=6a6f1855273, createdName=小甜甜66, createdTime=Tue Jul 04 07:37:19 CST 2023, time=2023-07-04, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2118088, encodeId=2339211808828, content=Research Square上能看到审稿进度。我1月31日投稿，2月17日分配编辑，3月2日邀请审稿人，邀请了两个，3月6日显示已经收到两个审稿意见。希望有个好结果🙏🏻🙏🏻🙏🏻🙏🏻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc388334751, createdName=ms1000000326683554, createdTime=Tue Mar 07 10:55:10 CST 2023, time=2023-03-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2133435, encodeId=80832133435b4, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：审稿速度超级慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99ec2258493, createdName=1217be29m97(暂无昵称), createdTime=Sat May 13 14:45:50 CST 2023, time=2023-05-13, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2124397, encodeId=55c4212439edc, content=二审要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/19/9fed0a27d14f8b827343de9cb3cd3267.jpg, createdBy=40602297737, createdName=伪面君子, createdTime=Sat Apr 08 02:42:05 CST 2023, time=2023-04-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2125067, encodeId=acde212506e1a, content=审稿速度:3.0 偏重的研究方向：基础研究并结合临床转化为特点 经验分享：这个杂志极其的慢，投稿后状态就是under review。杂志首页说的first decision日期为25天，指的是25天由编辑决定是否送外审。之后的外审还有1-2个月时间。除了韩国自己人的审稿速度快，，其他国家基本都是很慢的周期！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8da12982265, createdName=seudoctorxie, createdTime=Tue Apr 11 12:39:31 CST 2023, time=2023-04-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2127485, encodeId=b634212e485c8, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：审稿速度非常慢，投稿一个多月，editor都还没有处理，email杂志社也不回。对审稿速度有要求的，建议不要投该杂志。杂志社与主编处理稿件非常慢，无论是初次投稿，还是返修！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99ec2258493, createdName=1217be29m97(暂无昵称), createdTime=Fri Apr 21 14:57:54 CST 2023, time=2023-04-21, status=1, ipAttribution=重庆)]

2023-04-21 1217be29m97(暂无昵称) 来自重庆

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤
经验分享：审稿速度非常慢，投稿一个多月，editor都还没有处理，email杂志社也不回。对审稿速度有要求的，建议不要投该杂志。杂志社与主编处理稿件非常慢，无论是初次投稿，还是返修！！

31 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务